BIOMARIN PHARMACEUTICAL INC
BMRN·09061G101·US·Common Stock·Healthcare - Biotechnology-13D/G
BMRN (BIOMARIN PHARMACEUTICAL INC) is held by 216 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), DODGE & COX ($822.6M), PRIMECAP MANAGEMENT CO/CA/ ($801.8M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 118 funds bought BMRN.
216
Holders
Avg rating(41 Elite)
$9.1B
Total Value
53% (238)
Fund Consensus
118 buying - 105 selling
Who's Trading
InsiderFRFriberg Gregory RSell $177KMay 7, 2026
InsiderGGGuyer Charles GregSell $997KMar 11, 2026
InsiderDEDavis George EricSell $1.6MFeb 26, 2026
InsiderFRFriberg Gregory RSell $382KFeb 26, 2026
13F: Insider & Congress:
Showing 1-20 of 238
1 / 12
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer